Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%

BACKGROUND: The purpose of this study was to characterize intraocular pressure (IOP) reduction throughout the day with travoprost ophthalmic solution 0.004% dosed once daily in the evening. METHODS: The results of seven published, randomized clinical trials including at least one arm in which travop...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubiner, Harvey B, Noecker, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334204/
https://www.ncbi.nlm.nih.gov/pubmed/22536047
http://dx.doi.org/10.2147/OPTH.S30690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334204/
https://www.ncbi.nlm.nih.gov/pubmed/22536047
http://dx.doi.org/10.2147/OPTH.S30690

Ejemplares similares